Laos vs Paraguay: Access to anti-retroviral drugs, male (%)
Laos
61.0%
in 2024
Paraguay
61.0%
in 2024
Laos rank
97th
Paraguay rank
97th
Access to anti-retroviral drugs, male (%) over time
- Laos
- Paraguay
How they compare
Laos currently reports 61.0% against 61.0% in Paraguay, a difference of 0.0%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Paraguay ahead.
Laos ranks 97th and Paraguay ranks 97th of 141 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Laos | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.8% | 7.1% | 1.3% | Paraguay |
| 2010s | 25.4% | 34.0% | 8.6% | Paraguay |
| 2020s | 51.4% | 56.2% | 4.8% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Laos or Paraguay?
- Laos, at 61.0% against 61.0% in Paraguay as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Laos and Paraguay?
- 0.0%, with Laos ahead.
- How many years of comparable data are there for Laos and Paraguay?
- 24 years are reported by both, from 2000 to 2024.
- How do Laos and Paraguay rank globally for access to anti-retroviral drugs, male?
- Laos ranks 97th and Paraguay ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.